{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T03:27:10Z","timestamp":1784863630366,"version":"3.55.0"},"reference-count":30,"publisher":"BMJ","issue":"5","license":[{"start":{"date-parts":[[2020,5,24]],"date-time":"2020-05-24T00:00:00Z","timestamp":1590278400000},"content-version":"unspecified","delay-in-days":23,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1046999"],"award-info":[{"award-number":["GNT1046999"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1120353"],"award-info":[{"award-number":["GNT1120353"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"name":"GlaxoSmithKline"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2020,4,20]]},"published-print":{"date-parts":[[2020,5]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Streptococcus pneumoniae<\/jats:italic>\n                      and non-typeable\n                      <jats:italic>Haemophilus influenzae<\/jats:italic>\n                      (NTHi) are major otitis media pathogens that densely co-colonise the nasopharynx and infect the middle ear of Australian Aboriginal infants from very early in life. Our co-primary hypotheses are that at 18 months of age infants receiving 10-valent pneumococcal\n                      <jats:italic>Haemophilus influenzae<\/jats:italic>\n                      protein D conjugate vaccine (PHiD-CV10) compared with those receiving 13-valent pneumococcal conjugate vaccine (PCV13) as a booster at 12 months of age will have higher antibody levels to\n                      <jats:italic>Haemophilus influenzae<\/jats:italic>\n                      protein D and that infants receiving PCV13 will have higher antibody levels to PCV13-only serotypes 3, 6A and 19A.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analyses<\/jats:title>\n                    <jats:p>Our randomised controlled trial will enrol 270 Aboriginal children at 12 months of age to a booster dose of either PHiD-CV10 or PCV13. Children who completed the three-dose primary course schedules of PHiD-CV10 at 2, 4, 6 months of age; PCV13 at 2, 4, 6 months of age; or a combination schedule of PHiD-CV10 at 1, 2, 4 months of age plus PCV13 at 6 months of age are eligible. The co-primary assessor-blinded outcomes when the infants are 18\u2009months of age are as follows: (a) IgG geometric mean concentration (GMC) and proportion with IgG \u2265100 EU\/mL for protein D, and (b) IgG GMC and the proportion with IgG \u22650.35\u2009\u00b5g\/mL for pneumococcal serotypes 3, 6A and 19A. Secondary immunogenicity comparisons of six primary and booster dose schedules of 10 shared serotypes at 18 months of age, nasopharyngeal carriage, all forms of otitis media, hearing loss and developmental milestones at 18, 24, 30 and 36 months of age will be reported.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>Ethics committees of NT Department of Health, Menzies, WA Department of Health and WA Aboriginal Health approved the study. Results will be presented to communities, at conferences and published in peer-reviewed journals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" specific-use=\"clinicaltrial pre-results\" xlink:href=\"NCT01735084\">NCT01735084<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2019-033511","type":"journal-article","created":{"date-parts":[[2020,5,24]],"date-time":"2020-05-24T14:25:13Z","timestamp":1590330313000},"page":"e033511","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["10-Valent pneumococcal non-typeable\n                    <i>H. influenzae<\/i>\n                    protein D conjugate vaccine (PHiD-CV10) versus 13-valent pneumococcal conjugate vaccine (PCV13) as a booster dose to broaden and strengthen protection from otitis media (PREVIX_BOOST) in Australian Aboriginal children: study protocol for a randomised controlled trial"],"prefix":"10.1136","volume":"10","clinical-trial-number":[{"clinical-trial-number":"nct01735084","registry":"10.18810\/clinical-trials-gov","type":"preResults"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9505-7197","authenticated-orcid":false,"given":"Victor M","family":"Oguoma","sequence":"first","affiliation":[{"name":"Child Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Northern Territory, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Wilson","sequence":"additional","affiliation":[{"name":"Child Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Northern Territory, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Mulholland","sequence":"additional","affiliation":[{"name":"Infection and Immunity: Pneumococcal Research, Murdoch Childrens Research Institute, Parkville, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathuram","family":"Santosham","sequence":"additional","affiliation":[{"name":"Center American Indian Health, John Hopkins School of Public Health, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Torzillo","sequence":"additional","affiliation":[{"name":"Respiratory Medicine, Prince Alfred Hospital, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"McIntyre","sequence":"additional","affiliation":[{"name":"Director, National Centre for Immunisation Research and Surveillance, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Smith-Vaughan","sequence":"additional","affiliation":[{"name":"Child Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Northern Territory, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Balloch","sequence":"additional","affiliation":[{"name":"Pneumococcal Immunology, Murdoch Childrens Research Institute, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Chatfield","sequence":"additional","affiliation":[{"name":"Cerebral Palsy and Rehabilitation Research Centre, University of Queensland, Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Lehmann","sequence":"additional","affiliation":[{"name":"Division of Population Sciences, Telethon Institute for Child Health Research, West Perth, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J","family":"Binks","sequence":"additional","affiliation":[{"name":"Child Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Northern Territory, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Chang","sequence":"additional","affiliation":[{"name":"Child Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Northern Territory, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Carapetis","sequence":"additional","affiliation":[{"name":"Director, Telethon Kids Institute, Perth, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicki","family":"Krause","sequence":"additional","affiliation":[{"name":"Centre for Disease Control, Department of Health, Darwin, Northern Territory, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross","family":"Andrews","sequence":"additional","affiliation":[{"name":"Child Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Northern Territory, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Snelling","sequence":"additional","affiliation":[{"name":"Infectious Disease Implementation Research Team, Princess Margaret Hospital for Children, Perth, Western Australia, Australia"},{"name":"Wesfarmers Centre of Vaccines & Infectious Diseases, Telethon Kids Institute, West Perth, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Licciardi","sequence":"additional","affiliation":[{"name":"Infections and Immunity: Pneumococcal Research, Murdoch Childrens Research Institute, Melbourne, Victoria, Australia"},{"name":"Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Morris","sequence":"additional","affiliation":[{"name":"Child Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Northern Territory, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda Jane","family":"Leach","sequence":"additional","affiliation":[{"name":"Child Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Northern Territory, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,5,24]]},"reference":[{"key":"2025121300090845000_10.5.e033511.1","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199411000-00009"},{"key":"2025121300090845000_10.5.e033511.2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2431-14-200"},{"key":"2025121300090845000_10.5.e033511.3","doi-asserted-by":"crossref","first-page":"170","DOI":"10.33321\/cdi.2009.33.16","article-title":"Immunisation coverage annual report, 2007","volume":"33","author":"Hull","year":"2009","journal-title":"Commun Dis Intell Q Rep"},{"key":"2025121300090845000_10.5.e033511.4","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw720"},{"key":"2025121300090845000_10.5.e033511.5","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ics.2005.11.078","article-title":"Microbiology of acute otitis media with perforation (AOMwiP) in Aboriginal children living in remote communities\u2014monitoring the impact of 7-valent pneumococcal conjugate vaccine (7vPCV)","volume":"1289","author":"Leach","year":"2006","journal-title":"Int Congr Ser"},{"key":"2025121300090845000_10.5.e033511.6","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2431-9-14"},{"key":"2025121300090845000_10.5.e033511.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68304-9"},{"key":"2025121300090845000_10.5.e033511.8","doi-asserted-by":"publisher","DOI":"10.1186\/s12887-015-0483-8"},{"key":"2025121300090845000_10.5.e033511.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijporl.2016.05.011"},{"key":"2025121300090845000_10.5.e033511.10","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-007247"},{"key":"2025121300090845000_10.5.e033511.11","unstructured":"World Health Organization . Pneumococcal vaccines: who position paper\u20142012. Geneva, Switzerland, 2012: 129\u201344."},{"key":"2025121300090845000_10.5.e033511.12","unstructured":"Australian Technical Advisory Group on Immunisation (ATAGI) . Australian Immunisation Handbook, Australian Government Department of Health. Canberra, Australia: immunisationhandbook.health.gov.au, 2018."},{"key":"2025121300090845000_10.5.e033511.13","unstructured":"Central Australian Rural Practitioner Association . CARPA standard treatment manual: a clinic manual for primary health care practitioners in remote and rural communities in Central and Northern Australia. Alice Springs: Central Australian Rural Practitioner Association, 2003."},{"key":"2025121300090845000_10.5.e033511.14","unstructured":"WHO Expert Committee on Biological Standardization. WHO Technical Report Series 927. Geneva, Switzerland 2005."},{"key":"2025121300090845000_10.5.e033511.15","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.vaccine.2009.11.011","article-title":"Results from an inter-laboratory comparison of pneumococcal serotype-specific IgG measurement and critical parameters that affect assay performance","volume":"28","author":"Balloch","year":"2010","journal-title":"Vaccine"},{"key":"2025121300090845000_10.5.e033511.16","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e31816fca9d"},{"key":"2025121300090845000_10.5.e033511.17","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1007\/s10096-018-3314-7","article-title":"Bacteria and viruses in the nasopharynx immediately prior to onset of acute lower respiratory infections in Indigenous Australian children","volume":"37","author":"Smith-Vaughan","year":"2018","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2025121300090845000_10.5.e033511.18","doi-asserted-by":"publisher","DOI":"10.2217\/fmb-2016-0215"},{"key":"2025121300090845000_10.5.e033511.19","unstructured":"Morris P , Leach A , Shah P , et al . Recommendations for Clinical Care Guidelines on the Management of Otitis Media: In Aboriginal and Torres Strait Islander Populations 2010: Menzies School of Health 2011."},{"key":"2025121300090845000_10.5.e033511.20","unstructured":"Sheridan MD , Sharma A , Frost M . From birth to five years: children's developmental progress:. Routledge, 2002."},{"key":"2025121300090845000_10.5.e033511.21","doi-asserted-by":"publisher","DOI":"10.1136\/adc.84.1.45"},{"key":"2025121300090845000_10.5.e033511.22","unstructured":"TNO Prevention and Health . The TNO-AZL Infant Quality of Life questionnaire (in Dutch): Paediatric Department, and University of Leiden (TNO, Leiden, 1996."},{"key":"2025121300090845000_10.5.e033511.23","unstructured":"The International Fetal and Newborn Growth Consortium . International fetal and newborn growth standards for the 21st century. University of Oxford, 2014."},{"key":"2025121300090845000_10.5.e033511.24","doi-asserted-by":"publisher","DOI":"10.1177\/1049732311432717"},{"key":"2025121300090845000_10.5.e033511.25","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1016\/j.vaccine.2008.05.012","article-title":"Immunogenicity for 16 serotypes of a unique schedule of pneumococcal vaccines in a high-risk population","volume":"26","author":"Leach","year":"2008","journal-title":"Vaccine"},{"key":"2025121300090845000_10.5.e033511.26","doi-asserted-by":"crossref","first-page":"9675","DOI":"10.1016\/j.vaccine.2011.10.012","article-title":"Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine (PCV13) when given as a toddler dose to children immunized with PCV7 as infants","volume":"29","author":"Grimprel","year":"2011","journal-title":"Vaccine"},{"key":"2025121300090845000_10.5.e033511.27","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/cid\/cix419","article-title":"Immunogenicity of the 13-Valent pneumococcal conjugate vaccine in older adults with and without comorbidities in the community-acquired pneumonia immunization trial in adults (capita)","volume":"65","author":"van Deursen","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2025121300090845000_10.5.e033511.28","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00430-13"},{"key":"2025121300090845000_10.5.e033511.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.08.062"},{"key":"2025121300090845000_10.5.e033511.30","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c869"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2019-033511","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T08:09:13Z","timestamp":1765613353000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2019-033511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":30,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,5,24]]},"published-print":{"date-parts":[[2020,5]]}},"alternative-id":["10.1136\/bmjopen-2019-033511"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2019-033511","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5]]}}}